Center-Authored Papers
Filters: Author is Green, Damian J [Clear All Filters]
.
2014.
A prospective study of lenalidomide monotherapy for relapse after Allo-SCT for multiple myeloma.. Bone marrow transplantation. 49(4):492-5. Abstract
.
2014.
Mantle cell lymphoma international prognostic index but not pretransplantation induction regimen predicts survival for patients with mantle-cell lymphoma receiving high-dose therapy and autologous stem-cell transplantation.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(22):3023-9. Abstract
.
2011.
Long-term outcomes of patients with persistent indolent B cell malignancies undergoing nonmyeloablative allogeneic transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 21(2):281-7. Abstract
.
2015.
Specific features identify patients with relapsed or refractory mantle cell lymphoma benefitting from autologous hematopoietic cell transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 19(9):1403-6. Abstract
.
2013.
High-dose CD20-targeted radioimmunotherapy-based autologous transplantation improves outcomes for persistent mantle cell lymphoma.. British journal of haematology. 171(5):788-97. Abstract
.
2015.
Pre-transplantation novel agent induction predicts progression-free survival for patients with immunoglobulin light-chain amyloidosis undergoing high-dose melphalan and autologous stem cell transplantation.. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis. 23(4):254-259. Abstract
.
2016.
Results of a phase I-II study of fenretinide and rituximab for patients with indolent B-cell lymphoma and mantle cell lymphoma.. British journal of haematology. Abstract
.
2017.
.
2015.
Pulmonary embolization of fat and bone marrow in cynomolgus Macaques (Macaca fascicularis).. Comparative medicine. 61(1):86-91. Abstract
.
2011.
.
2015.
.
2014.
Whither Radioimmunotherapy: To Be or Not To Be? Cancer research. 77(9):2191-2196. Abstract
.
2017.
A Preclinical Model of CD38-Pretargeted Radioimmunotherapy for Plasma Cell Malignancies.. Cancer research. 74(4):1179-89. Abstract
.
2014.
.
2009.
.
2015.
A View from the Plateau: Is There a Role for Allogeneic Stem Cell Transplantation in the Era of Highly Effective Therapies for Multiple Myeloma? Current hematologic malignancy reports. Abstract
.
2017.
.
2016.
Pretargeted radioimmunotherapy for B-cell lymphomas.. Clinical cancer research : an official journal of the American Association for Cancer Research. 13(18 Pt 2):5598s-5603s. Abstract
.
2007.
Panobinostat: a review of trial results and future prospects in multiple myeloma.. Expert review of hematology. 8(1):9-18. Abstract
.
2015.
Radiolabeled Anti-CD45 Antibody with Reduced-Intensity Conditioning and Allogeneic Transplantation for Younger Patients with Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 20(9):1363-8. Abstract
.
2014.
.
2015.
Extracorporeal adsorption therapy: a method to improve targeted radiation delivered by radiometal-labeled monoclonal antibodies.. Cancer biotherapy & radiopharmaceuticals. 23(2):181-91. Abstract
.
2008.
Venetoclax Synergizes with Radiotherapy for Treatment of B cell Lymphomas.. Cancer research. 77(14):3885-3893. Abstract
.
2017.
.
2015.
Doing Business with Arnold Library
Weintraub Building, B1-010
(206) 667-4314
library@fredhutch.org
More About Arnold Library
Quick Links
- ILLiad/ILL Form
- Journals List
- Ovid - Medline
- Web of Science
- Pubmed
- Libguides
- Library Catalog
- Researcher Profiles
- Library Affiliations & Memberships
- Fred Hutch Papers (Intranet)